retatrutide dose escalation trial Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a Retatrutide Dosage Chart: 2mg to

Can cannabis affect weight-loss results

Lilly offers telemedicine options and free home delivery of Zepbound through Lilly Direct

Phase 4: Therapeutic dose (Weeks 13-16) Dose: 8 mg or 9 mg once weekly What to expect: Strong appetite suppression Significant ongoing weight loss Possible temporary GI flare during escalation Many reach 10-15% weight loss by this phase Tips: This is where most people stabilize 8 mg may be sufficient for manyhigher isn't always better Continue lifestyle optimization Regular check-ins with healthcare provider Phase 5: Maximum dose (Week 17+) Dose: 12 mg once weekly (if tolerated and needed) What to expect: Maximum therapeutic effect Continued weight loss (averaging 20%+ by 48 weeks in trials) GI side effects may be manageable or may persist Some achieve 25-30%+ weight loss Tips: Not everyone needs to reach 12 mg Lower doses may provide sufficient results Balance efficacy with tolerability Maintenance may involve dose reduction For general peptide dosing principles, see our peptide dosage calculator guide

Injections enhance metabolic efficiency but do not replace lifestyle changes

The clinical data suggests this engineering was successful

Once prescribed by our medical providers, your prescription is sent to our partner GLP-1 compounding pharmacy (or in some cases, another pharmacy of your choosing)